curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

Study to Evaluate the Safety of UF-KURE-BCMA CAR T-Cells in Advanced Myeloma

by palligoelme@gmail.com | May 28, 2026 | Clinical Trials

​ Conditions: Multiple Myeloma in Relapse; Multiple Myeloma, Refractory Interventions: Biological: Administration of CAR T-cells at 3 different dose levels Sponsors: Kure Cells, INC; CellServe LLC; Roya Clinical Not yet recruiting Conditions: Multiple Myeloma in...

Real-World Patterns of Utilization of Lenalidomide-based Triplet Regimens in FIrst RElapsed Multiple Myeloma Patients: Evidence From Medical Record Review

by palligoelme@gmail.com | May 28, 2026 | Clinical Trials

​ Conditions: Multiple Mieloma; First Relpase; Rd-base Triplet Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia Completed Conditions: Multiple Mieloma; First Relpase; Rd-base Triplet Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia...

Active Versus Passive Anal Sphincter Training in Patients With Fecal Incontinence

by palligoelme@gmail.com | May 28, 2026 | Clinical Trials

​ Conditions: Fecal Incontinence Interventions: Device: Home-based anal electrical stimulator Sponsors: University Hospital, Martin; Comenius University Recruiting Conditions: Fecal Incontinence Interventions: Device: Home-based anal electrical stimulator Sponsors:...

Oral Health and Systemic Diseases: Survey of General Practitioners

by palligoelme@gmail.com | May 28, 2026 | Clinical Trials

​ Conditions: Periodontal Disease; Diabete Mellitus Interventions: Other: Questionnaire Survey Sponsors: University of Roma La Sapienza Recruiting Conditions: Periodontal Disease; Diabete Mellitus Interventions: Other: Questionnaire Survey Sponsors: University of Roma...

SKB315 in Combination Therapy in Patients With Advanced or Metastatic GC/ GEJ Adenocarcinoma

by palligoelme@gmail.com | May 27, 2026 | Clinical Trials

​ Conditions: Gastroesophageal Junction Adenocarcinoma Interventions: Drug: Tislelizumab; Drug: SKB315 for injection; Drug: Capecitabine Sponsors: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Not yet recruiting Conditions: Gastroesophageal Junction Adenocarcinoma...

Assessment of Endoscopic Tip Control Using a Novel Score Based on Snare Tip Soft Coagulation of ex Vivo Model (HAM STUDY)

by palligoelme@gmail.com | May 27, 2026 | Clinical Trials

​ Conditions: Evaluating Endoscopist Tip Control During STSC Application Interventions: Procedure: Ham-based Assessment Model Sponsors: University Hospital, Ghent Recruiting Conditions: Evaluating Endoscopist Tip Control During STSC Application Interventions:...
« Older Entries
Next Entries »

Recent Posts

  • FMT for 90-Day Outcome of Clinical Use in ICU Sepsis
  • Resistance Training and Capillarization – Role on the Anabolic Response in Older Adults
  • Effects of a Nurse-Led Self-Compassion and Kindness Program on Compassion and Healthy Peer Relationships in Adolescents
  • STRIDE: Strength of The Calf Muscles and Their Role In Declining Effectiveness of Movement With Aging
  • A Study of Tetanus Antibody of Healthy Adults

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®